BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 33562655)

  • 1. Cutting Edge of the Pathogenesis of Atopic Dermatitis: Sphingomyelin Deacylase, the Enzyme Involved in Its Ceramide Deficiency, Plays a Pivotal Role.
    Imokawa G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingomyelin Deacylase, the Enzyme Involved in the Pathogenesis of Atopic Dermatitis, Is Identical to the β-Subunit of Acid Ceramidase.
    Teranishi Y; Kuwahara H; Ueda M; Takemura T; Kusumoto M; Nakamura K; Sakai J; Kimura T; Furutani Y; Kawashima M; Imokawa G; Nogami-Itoh M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide.
    Imokawa G
    J Dermatol Sci; 2009 Jul; 55(1):1-9. PubMed ID: 19443184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis.
    Hara J; Higuchi K; Okamoto R; Kawashima M; Imokawa G
    J Invest Dermatol; 2000 Sep; 115(3):406-13. PubMed ID: 10951276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide.
    Higuchi K; Hara J; Okamoto R; Kawashima M; Imokawa G
    Biochem J; 2000 Sep; 350 Pt 3(Pt 3):747-56. PubMed ID: 10970788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reevaluation of the non-lesional dry skin in atopic dermatitis by acute barrier disruption: an abnormal permeability barrier homeostasis with defective processing to generate ceramide.
    Sugiura A; Nomura T; Mizuno A; Imokawa G
    Arch Dermatol Res; 2014 Jul; 306(5):427-40. PubMed ID: 24271939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency?
    Murata Y; Ogata J; Higaki Y; Kawashima M; Yada Y; Higuchi K; Tsuchiya T; Kawainami S; Imokawa G
    J Invest Dermatol; 1996 Jun; 106(6):1242-9. PubMed ID: 8752664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis.
    Okamoto R; Arikawa J; Ishibashi M; Kawashima M; Takagi Y; Imokawa G
    J Lipid Res; 2003 Jan; 44(1):93-102. PubMed ID: 12518027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal expression of the novel epidermal enzyme, glucosylceramide deacylase, and the accumulation of its enzymatic reaction product, glucosylsphingosine, in the skin of patients with atopic dermatitis.
    Ishibashi M; Arikawa J; Okamoto R; Kawashima M; Takagi Y; Ohguchi K; Imokawa G
    Lab Invest; 2003 Mar; 83(3):397-408. PubMed ID: 12649340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Levels of Sphingosine, Sphinganine and Their Ceramides in Atopic Dermatitis Are Related to Skin Barrier Function, Disease Severity and Local Cytokine Milieu.
    Toncic RJ; Jakasa I; Hadzavdic SL; Goorden SM; Vlugt KJG; Stet FS; Balic A; Petkovic M; Pavicic B; Zuzul K; Marinovic B; Kezic S
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with Synthetic Pseudoceramide Improves Atopic Skin, Switching the Ceramide Profile to a Healthy Skin Phenotype.
    Ishida K; Takahashi A; Bito K; Draelos Z; Imokawa G
    J Invest Dermatol; 2020 Sep; 140(9):1762-1770.e8. PubMed ID: 32014509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of epidermal lipid bio-synthesis enzymes in atopic dermatitis skin is accompanied by changes in stratum corneum lipid composition.
    Danso M; Boiten W; van Drongelen V; Gmelig Meijling K; Gooris G; El Ghalbzouri A; Absalah S; Vreeken R; Kezic S; van Smeden J; Lavrijsen S; Bouwstra J
    J Dermatol Sci; 2017 Oct; 88(1):57-66. PubMed ID: 28571749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1 cytokines accentuate but Th2 cytokines attenuate ceramide production in the stratum corneum of human epidermal equivalents: an implication for the disrupted barrier mechanism in atopic dermatitis.
    Sawada E; Yoshida N; Sugiura A; Imokawa G
    J Dermatol Sci; 2012 Oct; 68(1):25-35. PubMed ID: 22884781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis.
    Ohnishi Y; Okino N; Ito M; Imayama S
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):101-4. PubMed ID: 9874672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Children with atopic dermatitis show increased activity of β-glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to the local cytokine milieu.
    Kezic S; McAleer MA; Jakasa I; Goorden SMI; der Vlugt KG; Beers-Stet FS; Meijer J; Roelofsen J; Nieman MM; van Kuilenburg ABP; Irvine AD
    Br J Dermatol; 2022 Jun; 186(6):988-996. PubMed ID: 34993951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ceramides in barrier function of healthy and diseased skin.
    Choi MJ; Maibach HI
    Am J Clin Dermatol; 2005; 6(4):215-23. PubMed ID: 16060709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atopic xerosis: employment of noninvasive biophysical instrumentation for the functional analyses of the mildly abnormal stratum corneum and for the efficacy assessment of skin care products.
    Tagami H; Kobayashi H; O'goshi K; Kikuchi K
    J Cosmet Dermatol; 2006 Jun; 5(2):140-9. PubMed ID: 17173589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis.
    Schmuth M; Man MQ; Weber F; Gao W; Feingold KR; Fritsch P; Elias PM; Holleran WM
    J Invest Dermatol; 2000 Sep; 115(3):459-66. PubMed ID: 10951284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin of atopic dermatitis patients shows disturbed β-glucocerebrosidase and acid sphingomyelinase activity that relates to changes in stratum corneum lipid composition.
    Boer DEC; van Smeden J; Al-Khakany H; Melnik E; van Dijk R; Absalah S; Vreeken RJ; Haenen CCP; Lavrijsen APM; Overkleeft HS; Aerts JMFG; Bouwstra JA
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158673. PubMed ID: 32092464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sphingomyelin/ceramide ratio on the permeability and microstructure of model stratum corneum lipid membranes.
    Pullmannová P; Staňková K; Pospíšilová M; Skolová B; Zbytovská J; Vávrová K
    Biochim Biophys Acta; 2014 Aug; 1838(8):2115-26. PubMed ID: 24824073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.